Breast conservation treatment in women with locally advanced breast cancer - Experience from a single centre

International Journal of Surgery

Volumn 4, Issue 2, 2006, Pages 106-114

  Parmar, V ^a   Krishnamurthy, A ^a   Hawaldar, R ^a   Nadkarni, M S ^a   Sarin, R ^a   Chinoy, R ^a   Nair, R ^a   Dinshaw, K A ^a   Badwe, R A ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Breast conservation; Local recurrence; Locally advanced breast cancer

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; TAMOXIFEN;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CENTER; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; DISEASE FREE INTERVAL; DRUG RESPONSE; EMBOLISM; EXPERIENCE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; INDIA; LYMPHATIC SYSTEM DISEASE; MAJOR CLINICAL STUDY; MASTECTOMY; MINIMAL RESIDUAL DISEASE; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RELAPSE; SAFETY;

EID: 33747071522     PISSN: 17439191     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijsu.2006.01.004     Document Type: Article

References (23)

1. Hortobagyi G.N., Ames F.C., Buzdar A.U., Kau S.W., McNeese M.D., Paulus D., et al. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer 62 (1998) 2507-2516
2. Mauriac L., MacGrogan G., Avril A., et al. Effects of primary chemotherapy for operable breast cancer more than 3 cm; a unicentre randomised trial with 124 month-median follow up. Institut Bergonie Bordeaux Groupe Sein (IBBGS). Ann Oncol 10 (1999) 47-52
3. Baillet F, Rozec C, Ucla L, Chauveinc L, Housset M, Weil M. Treatment of locally advanced breast cancer without mastectomy: 5- and 10-yr results of 135 tumors larger than 5 cm treated by external beam therapy, brachytherapy and neoadjuvant chemotherapy. In Pisa Symposia in Oncology. Breast Cancer from Biology to Therapy, 1992. p. 22 [abstract].
4. Vlastos G., Mirza N.Q., Lenert J.T., Hunt K.K., Ames F.C., Feig B.W., et al. The feasibility of minimally invasive surgery for stage IIA, IIB, and IIIA breast carcinoma patients after tumor downstaging with induction chemotherapy. Cancer 88 6 (2000 Mar 15) 1417-1424
5. El-Didi M.H., Moneer M.M., Khaled H.M., and Makarem S. Pathological assessment of the response of locally advanced breast cancer to neoadjuvant chemotherapy and its implications for surgical management. Surg Today 30 3 (2000) 249-254
6. Pierga J.Y., Mouret E., Dieras V., Laurence V., Beuzeboc P., Dorval T., et al. Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer. Br J Cancer 83 11 (2000 Dec) 1480-1487
7. Kuerer H.M., Sahin A.A., Hunt K.K., Newman L.A., Breslin T.M., Ames F.C., et al. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg 230 1 (1999 Jul) 72-78
8. Gajdos C., Tartter P.I., Estabrook A., Gistrak J.S., and Bleiweiss I.J. Relationship of clinical and pathological response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer. J Surg Oncol 80 (2002) 4-11
9. Kuerer H.M., Newman L.A., Smith T.L., Ames F.C., Hunt K.K., Dhingra K., et al. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol 17 2 (1999 Feb) 460-469
10. Heys S.D., Sarkar T., and Hutcheon A.W. Primary docetaxel chemotherapy in patients with breast cancer - Impact on response and survival. Breast Cancer Res Treat 90 2 (2005 March) 169-185
11. Bartelink H., Rubens R.D., van der Schueren E., and Sylvester R. Hormonal therapy prolongs survival in irradiated locally advanced breast cancer: a European Organization for Research and Treatment of Cancer Randomized Phase III Trial. J Clin Oncol 15 (1997) 207-215
12. Touboul E., Lefranc J.P., Blondon J., Buffat L., Deniaud E., Belkacemi Y., et al. Primary chemotherapy and preoperative irradiation for patients with stage II larger than 3 cm or locally advanced non-inflammatory breast cancer. Radiother Oncol 42 (1997) 219-229
13. Merajver S.D., Weber B.L., Cody R., Zhang D., Strawderman M., Calzone K.A., et al. Breast conservation and prolonged chemotherapy for locally advanced breast cancer: the University of Michigan experience. J Clin Oncol 15 (1997) 2873-2881
14. Cance W.G., Carey L.A., Calvo B.F., Sartor C., Sawyer L., Moore D.T., et al. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival. Ann Surg 236 (2002) 295-303
15. Clark J., Rosenman J., Cance W., Halle J., and Graham M. Extending the indications for breast-conserving treatment to patients with locally advanced breast cancer. Int J Radiat Oncol Biol Phys 42 (1998) 345-350
16. McIntosh S.A., Ogston K.N., Payne S., Miller I.D., Sarkar T.K., Hutcheon A.W., et al. Local recurrence in patients with large and locally advanced breast cancer treated with primary chemotherapy. Am J Surg 185 (2003) 525-531
17. Chen A.M., Meric-Bernstam F., Hunt K.K., Thames H.D., Oswald M.J., Outlaw E.D., et al. Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. JCO 22 (2004) 2303-2312
18. Scholl S.M., Fourquet A., Asselain B., Pierga J.Y., Vilcoq J.R., Durand J.C., et al. Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumors considered too large for breast conserving surgery: preliminary results of a randomised trial: S6. Br J Surg 83 2 (1996 Feb) 149-155
19. Buchholz T.A., Tucker S.L., Masullo L., Kuerer H.M., Erwin J., Salas J., et al. Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation. Eur J Cancer 30A (1994) 645-652
20. Jacquillat C., Weil M., Baillet F., Borel C., Auclerc G., de Maublanc M.A., et al. Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer. Am J Surg 176 6 (1998 Dec) 502-509
21. Macmillan R.D., Purushotham A.D., and George W.D. Local recurrence after breast-conserving surgery for breast cancer. Br J Surg 83 2 (1996 Feb) 149-155
22. Kuerer H.M., Newman L.A., Buzdar A.U., Hunt K.K., Dhingra K., Buchholz T.A., et al. Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer. Cancer 66 (1990) 119-129
23. Ahern V., Barraclough B., Bosch C., Langlands A., and Boyages J. Locally advanced breast cancer: defining an optimum treatment regimen. Int J Radiat Oncol Biol Phys 28 (1994) 867